The latest price target for ProMIS Neurosciences (NASDAQ:PMN) was reported by BTIG on October 3, 2023. The analyst firm set a price target for $8.00 expecting PMN to rise to within 12 months (a possible 258.74% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for ProMIS Neurosciences (NASDAQ:PMN) was provided by BTIG, and ProMIS Neurosciences initiated their buy rating.

There is no last upgrade for ProMIS Neurosciences

There is no last downgrade for ProMIS Neurosciences.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProMIS Neurosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProMIS Neurosciences was filed on October 3, 2023 so you should expect the next rating to be made available sometime around October 3, 2024.

While ratings are subjective and will change, the latest ProMIS Neurosciences (PMN) rating was a initiated with a price target of $0.00 to $8.00. The current price ProMIS Neurosciences (PMN) is trading at is $2.23, which is within the analyst’s predicted range.